Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details)

v3.23.3
Stockholders’ Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 9 Months Ended
Jul. 20, 2023
Jul. 04, 2023
Jun. 13, 2023
Feb. 02, 2023
Jun. 14, 2022
Sep. 30, 2023
Sep. 30, 2022
Jul. 31, 2023
Feb. 28, 2023
Feb. 01, 2023
Dec. 31, 2022
Stockholders’ Equity (Details) [Line Items]                      
Preferred stock, shares authorized           50,000,000         50,000,000
Preferred stock, par value (in Dollars per share)           $ 0.0001         $ 0.0001
Preferred stock, shares issue and outstanding                  
Preferred stock issuance (in Dollars)           $ 855        
Aggregate principal amount (in Dollars)   $ 600                  
Shares issued   576                  
Aggregate shares of common stock           592,137          
Exercise price (in Dollars per share)           $ 8.868          
Converted preferred shares               2,930      
Shares of common stock           3,986,991          
Warrant fair value (in Dollars)           $ 200          
Common stock, shares authorized           800,000,000         800,000,000
Exercise of warrants           362,657          
Weighted average price per share (in Dollars per share)           $ 0.36          
Commissions and expenses (in Dollars)           $ 4,500          
Weighted-average price per share (in Dollars per share)           $ 1.19          
Aggregate amount (in Dollars) $ 50,000                    
Outstanding common stock percentage 4.99%                    
ELOC purchase agreement percentage           97.00%          
ELOC purchase agreement description           the Company issued 21,841 shares of common stock to the ELOC Purchase as an initial fee for commitment to purchase the Company’s common stock under the ELOC Purchase Agreement. On the date that is the earlier of (i) 30 calendar days after the Closing Date or (2) October 16, 2023, the Company will issue an additional 87,417 shares of common stock as additional commitment shares. Liability for common stock issued was $0.4 million as of the closing date. The liability is subject to remeasurement at each reporting period until issued, and any change in fair value is recognized and included as other income (expense) in the condensed consolidated statement of operations. The change in fair value of liability issued was approximately $0.4 million during the nine months ended September 30, 2023.          
Common Stock [Member]                      
Stockholders’ Equity (Details) [Line Items]                      
Shares of common stock               103,234      
Warrant Exercises [Member]                      
Stockholders’ Equity (Details) [Line Items]                      
Common stock shares issued           106,764          
Exercise of warrants           106,768          
Net proceeds (in Dollars)           $ 2,000          
Weighted average price per share (in Dollars per share)           $ 19.3          
Penny Warrants [Member]                      
Stockholders’ Equity (Details) [Line Items]                      
Exercise of warrants           2,778          
Warrant [Member] | Warrant Exercises [Member]                      
Stockholders’ Equity (Details) [Line Items]                      
Common stock shares issued           2,493          
Series A Preferred Stock [Member]                      
Stockholders’ Equity (Details) [Line Items]                      
Preferred stock, shares authorized           300         300
Preferred stock, par value (in Dollars per share)           $ 0.0001         $ 0.0001
Preferred stock, shares issue and outstanding           251         251
Series B Preferred Stock [Member]                      
Stockholders’ Equity (Details) [Line Items]                      
Preferred stock, shares authorized           1,500         1,500
Preferred stock, par value (in Dollars per share)           $ 0.0001         $ 0.0001
Preferred stock, shares issue and outstanding           1,443         1,443
Series C Preferred Stock [Member]                      
Stockholders’ Equity (Details) [Line Items]                      
Preferred stock, shares authorized           600,000         600,000
Preferred stock, par value (in Dollars per share)           $ 0.0001         $ 0.0001
Preferred stock, shares issue and outstanding           500,756         500,756
Series D Preferred Stocks [Member]                      
Stockholders’ Equity (Details) [Line Items]                      
Preferred stock, shares issue and outstanding                     1,058
Preferred stock, shares issued                    
Series E Preferred Stock [Member]                      
Stockholders’ Equity (Details) [Line Items]                      
Preferred stock, shares authorized           77,000       77,000 77,000
Preferred stock, par value (in Dollars per share)           $ 0.0001       $ 0.0001 $ 0.0001
Preferred stock, shares issue and outstanding                  
Preferred stock, shares issued       5,000          
Commitment fee with fair value (in Dollars)       $ 1,500              
Additional shares       5,000              
Fair value of additional shares       10,000              
Preferred stock issuance (in Dollars)       $ 2,900              
Fair value of additional capital (in Dollars)       $ 4,400              
Series F Preferred Stock [Member]                      
Stockholders’ Equity (Details) [Line Items]                      
Preferred stock, shares authorized           9,073         9,073
Preferred stock, par value (in Dollars per share)           $ 0.0001         $ 0.0001
Preferred stock, shares issue and outstanding           4,448        
Aggregate principal amount (in Dollars)   $ 2,600                  
Shares issued   2,622                  
Preferred shares issued   1,847                  
Preferred stock, description           For the 2022 Note holders, the total fair value of Series F preferred stock and warrant liability issued were $1.1 million and $0.6 million, respectively. For the Senior Secured Note holders, the total fair value of Series F preferred stock and warrant liability issued were $0.1 million and $30,000, respectively. For the Demand Note holders, the total fair value of Series F Preferred Stock and Warrant Liability issued were $0.2 million and $0.2 million, respectively. For the purchasers of the Company’s Series D preferred stock, the Company accounted for the exchange as an extinguishment of the Series D preferred stock and recorded the total fair value of Series F preferred Stock and warrant liability of $0.7 million and $0.5 million, respectively. The difference of $0.5 million with the $0.7 million carrying value of the Series D preferred stock as a deemed dividend and reduction to additional-paid-in-capital.          
Converted preferred shares               803      
Exercise of warrants           592,137          
Series F Preferred Stock [Member] | Senior Secured Notes [Member]                      
Stockholders’ Equity (Details) [Line Items]                      
Aggregate principal amount (in Dollars)   $ 200                  
Shares issued   206                  
Series D Preferred Stock [Member]                      
Stockholders’ Equity (Details) [Line Items]                      
Preferred stock, shares authorized           7,000         7,000
Preferred stock, par value (in Dollars per share)           $ 0.0001         $ 0.0001
Preferred stock, shares issue and outstanding                   1,058
Preferred stock, shares issued                   1,058
Preferred shares issued   1,197                  
Series F-1 Preferred Stock [Member]                      
Stockholders’ Equity (Details) [Line Items]                      
Preferred stock, shares authorized           9,052         9,052
Preferred stock, par value (in Dollars per share)           $ 0.0001         $ 0.0001
Preferred stock, shares issue and outstanding           653        
Shares issued     3,583                
Shares of common stock               325,737      
Aggregate purchase price (in Dollars)     $ 2,300                
Aggregate shares     398,377                
Warrants exercise price (in Dollars per share)     $ 8.994                
Proceeds of warrant liability (in Dollars)           $ 2,300          
Warrant fair value (in Dollars)           900          
Remaining proceeds (in Dollars)           $ 1,400          
Series F-2 Preferred Stock [Member]                      
Stockholders’ Equity (Details) [Line Items]                      
Preferred stock, shares authorized           9,052         9,052
Preferred stock, par value (in Dollars per share)           $ 0.0001         $ 0.0001
Preferred stock, shares issue and outstanding           1,153        
Shares issued         1,153            
Aggregate purchase price (in Dollars)         $ 700            
Aggregate shares         124,946            
Warrants exercise price (in Dollars per share)         $ 9.228            
Proceeds of warrant liability (in Dollars)           $ 700          
Warrant fair value (in Dollars)           300          
Remaining proceeds (in Dollars)           $ 400          
Board of Directors [Member] | Series E Preferred Stock [Member]                      
Stockholders’ Equity (Details) [Line Items]                      
Convertible shares                   1,000  
Line of Credit [Member]                      
Stockholders’ Equity (Details) [Line Items]                      
Additional shares       10,000              
Shares issued                 45,000    
At-the-Market Offerings [Member]                      
Stockholders’ Equity (Details) [Line Items]                      
Shares of common stock           794,689          
Market offering price (in Dollars)           $ 3,800          
Commissions and expenses (in Dollars)           $ 100          
Weighted-average price per share (in Dollars per share)           $ 4.98